CD4 and metabolic dysfunction-associated steatotic liver disease: Wilcoxon test revealed significant differences in activated CD4 T cells, CD56bright natural killer (NK) cells, T helper Type 1 (Th1) cells, activated B cells, CD56dim NK cells, Th17 cells, eosinophils, and Th2 cells between NAFLD and control groups (p < 0.05).